Home › Funds › Almitas Capital LLC › ALXO

Almitas Capital LLC position in ALXO

ALX ONCOLOGY HLDGS INC · Health Care

Almitas Capital LLC reported holding 2,938,431 shares of ALXO (ALX ONCOLOGY HLDGS INC) in its Q2 2026 13F filing — a position valued at US$6.1M, representing 1.46% of its reported portfolio and ranking #16 among its reported holdings. Almitas Capital LLC has disclosed ALXO holdings in 7 of the last 7 reported quarters, going back to Q4 2024.

Latest position (Q2 2026)2.94M sh
Reported value held$6.08M
Portfolio Weight1.46%
First reportedQ4 2024
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Almitas Capital LLC's ALXO position evolved

Almitas Capital LLC first disclosed a stake in ALXO in Q4 2024 at 1,222,945 shares (US$2.0M). The position peaked in Q1 2026 at 3,173,834 shares, worth US$6.4M. Across 7 filings, Almitas Capital LLC increased the stake 3 time(s), trimmed it 1 time(s) and left it unchanged 2 time(s). The most recent filing (Q2 2026) shows 2,938,431 shares valued at US$6.1M — a reduction of -235,403 shares quarter over quarter.. Notable position changes include a 88% increase in Q2 2025 (shares rose 341% over the following quarter), a 25% increase in Q1 2026 (shares rose 3% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2024 1.22M $2.04M New
Q1 2025 1.35M $843.01K Add
Q2 2025 2.54M $1.05M Add
Q3 2025 2.54M $4.64M Hold
Q4 2025 2.54M $2.87M Hold
Q1 2026 3.17M $6.36M Add
Q2 2026 2.94M $6.08M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ALXO and 13F data

ALXO (ALX ONCOLOGY HLDGS INC) is a Health Care company. 35 other funds we track also report a position in ALXO — the largest reported positions include venBio Partners LLC (US$26.7M), Redmile Group, LLC (US$15.3M), SILVERARC CAPITAL MANAGEMENT, LLC (US$11.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ALXO

All ALXO fund holders →

FAQ

How long has Almitas Capital LLC held ALXO?

Almitas Capital LLC has disclosed ALXO holdings in 7 of the last 7 reported quarters, going back to Q4 2024.

What is Almitas Capital LLC's current position in ALXO?

As of Q2 2026, Almitas Capital LLC holds 2.94M shares of ALXO (ALX ONCOLOGY HLDGS INC), valued at $6.08M, representing 1.46% of its reported portfolio and ranking #16.

Has Almitas Capital LLC been buying or selling ALXO?

In the latest 13F filing (Q2 2026), Almitas Capital LLC reduced its position in ALXO. The position peaked in Q1 2026 at 3.17M shares.

Which other funds hold ALXO?

Other major institutional holders of ALXO include venBio Partners LLC, Redmile Group, LLC, SILVERARC CAPITAL MANAGEMENT, LLC, among 35 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.